Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,826 shares at $51.37 ($195K) on 2021-11-02, disclosed to the SEC on 2021-11-03.
Open-market sale of $195k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.78 | 1,174 | $58K | 30.0% |
| 2 | $51.37 | 1,326 | $68K | 35.0% |
| 3 | $51.37 | 1,326 | $68K | 35.0% |
| Total | $50.88 avg | 3,826 | $195K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |